sixth wave innovations

Sixth Wave Announces Acquisition of Geolithic Corp.

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to announce an amendment to the Option Agreement with TriLateral Energy LLC ("TriLateral"), and the acquisition of 100% of the outstanding common shares of Geolithic Corp ("Geolithic").

Geolithic was established in January of 2017 as a joint venture between TriLateral and Sixth Wave to exploit the latter's technology for the extraction of lithium from geothermal brines located primarily in the Salton Sea area of California. The Salton brines are renowned for their elevated levels of lithium and represent one of the largest untapped sources of lithium in the world. Pursuant to the original 2017 agreement, TriLateral held 60% of the outstanding shares of Geolithic, with Sixth Wave holding 40%. Under the terms of updated Agreement, Sixth Wave has acquired 100% of the issued and outstanding Common Shares of Geolithic.

The Option Agreement originally called for a series of three payments to be made by Sixth Wave to TriLateral, totalling USD$300,000. To date, the Company has made the 1st Payment in the amount of USD$75,000 and a payment in the amount of USD$10,000 against the 2nd Payment. Remaining balances owing, in the amount of USD$215,000, have been settled by way of the issue of 800,000 common shares of the Company.

Lithium is a key material for certain types of batteries and is consequently receiving increased interest as electric and hybrid-electric vehicles see increased market penetration. Traditional processing techniques involve the use of evaporation ponds where lithium-rich brines are pumped into brine holding facilities, and water is naturally evaporated by the sun and air. The resultant concentrate is then harvested and post-processed to yield lithium carbonate. The process can take up to 18 months and has come under fire as concerns grow over the depletion of the water table and disposal of waste products.

"While our primary focus had been centered on the Salton Sea brines, the Company has had growing interest in its patent pending technology and our prototype extraction media from other brine and hard rock sources of lithium. Moreover, the growing use of lithium in a range of batteries supporting the automotive, electric grid, and solar/wind power industries brings into focus the need not only to mine new lithium but also to recycle lithium. Battery recycling, in particular, is an application for our existing designs that lacks some of the complexities of the mining side and for which our technology may be uniquely suited and cost effective. With the completion of this deal the Company will be free to exploit the interest it has developed over the past year," notes Dr. Jonathan Gluckman, President and CEO of Sixth Wave.

Debt Settlement

The Company further announces that it has re-negotiated the settlement of debt outstanding in the amount of USD$333,218. A total of USD$166,609 has been settled by the issuance of 667,335 common shares of the Company.

A total of USD$83,304 has been repaid. A final amount of USD$83,304 plus interest is to be repaid in September 2022. As a result of the re-negotiation, the Company has reduced its current liabilities by a total of USD$333,218.

Corporate Update

The Company reports that it has engaged Lion Capital Investment Limited for the provision of consulting and marketing services on behalf of the Company. Lion will provide general consulting services and will provide marketing services under the trade name Wallstreet Investor Club. The Company has paid Lion a total of $150,000 for a 12-month contract, with further payments in the amount of $250,000 for digital advertising.

The Company is in the process of establishing a Disclosure Policy with respect to marketing initiatives primarily focused on investors. Further to this effort, the Company reports that it entered into service agreements with Investing News Network on September 7, 2020 for the provision of marketing and lead generation at a cost of $50,000 and with Mountain Capital Corp on September 15, 2020 at a cost of $100,000 for the provision of digital marketing services.

About Sixth Wave

Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as, IXOS®, a line of extraction polymers for the gold mining industry. The Company is in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPs™) label.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for the detection and separation of viruses, biogenic amines, and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit our web site at: www.sixthwave.com

ON BEHALF OF THE BOARD OF DIRECTORS

"Jonathan Gluckman"
Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company:
Phone: (801) 582-0559
E-mail: info@sixthwave.com

Cautionary Notes (this needs tiding for this press release)

This press release includes certain statements that may be deemed "forward-looking statements" including statements regarding the performance of technologies. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. In particular, successful development and commercialization of the technology are subject to the risk that the technology may not prove to be successful in capturing lithium and the need for additional capital to carry out product development activities. The value of any products ultimately developed could be negatively impacted if the patent is not granted. The Company has not yet completed the development of a prototype for the product that is subject of its patent application and has not yet applied for regulatory approval for the use of this product from any regulatory agency.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81013

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare.

But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no indication that US hospitals are stockpiling equipment ahead of expected price hikes, according to recent findings from GlobalData.

Keep reading...Show less
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This establishes the timeline for the planned safety and efficacy futility interim analysis by an independent Data Monitoring Committee (DMC).

Keep reading...Show less
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access Emyria’s Empax PTSD care program delivered in association with Perth Clinic.

Keep reading...Show less
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will integrate HITIQ’s PROTEQT technology. The result is a fully developed, market-ready solution that merges HITIQ’s smart sensor technology with Shock Doctor’s unmatched global production partner capabilities.

Keep reading...Show less
HeartSciences Inc

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems

Keep reading...Show less
Zoono Group

Exclusive UK Packaging Agreement signed between Sharpak Aylesham Limited, Zoono, and OSY

Zoono Group Limited (Company) (ASX: ZNO) is pleased to update the market on an exclusive contract signed with Sharpak Aylesham Limited (Sharpak) and the Company’s partner in the food supply chain sector, OSY Group Limited (OSY).

Keep reading...Show less

Latest Press Releases

Related News

×